Loading…

The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System

Esophagogastroduodenoscopy (EGD) appropriateness in Open-Access System (OAS) is a relevant issue. The Gastropack Access System (GAS) is a new system to access gastroenterological services, based on the partnership between Gastroenterologists and GPs. This study aims to evaluate if GAS is superior to...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2023-05, Vol.12 (9), p.3343
Main Authors: Ceroni, Liza, Lodato, Francesca, Tubertini, Paolo, Marasco, Giovanni, Gazzola, Alessia, Biselli, Maurizio, Fabbri, Cristiano, Buonfiglioli, Federica, Ferrara, Francesco, Schiumerini, Ramona, Fabbri, Andrea, Tassoni, Alessandra, Descovich, Carlo, Mondini, Sandra, Tosetti, Cesare, Veduti, Valerio, De Negri, Mario, Fini, Alessandro, Guicciardi, Stefano, Romanelli, Massimo, Navarra, Giuseppe Giovanni, Barbara, Giovanni, Cennamo, Vincenzo, On Behalf Of Gastropack System Study Group
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Esophagogastroduodenoscopy (EGD) appropriateness in Open-Access System (OAS) is a relevant issue. The Gastropack Access System (GAS) is a new system to access gastroenterological services, based on the partnership between Gastroenterologists and GPs. This study aims to evaluate if GAS is superior to OAS in terms of EGDS appropriateness. Secondarily, we evaluated the diagnostic yield of EGDS according to ASGE guidelines. The GAS was developed in an area of Bologna where General Practitioners (GPs) could decide to directly prescribe EGDS through OAS or referring to GAS, where EGDS can be scheduled after contact between GPs and specialists sharing a patient's clinical information. Between 2016 and 2019, 2179 cases (M:F = 861:1318, median age 61, IQR 47.72) were referred to GAS and 1467 patients (65%) had a prescription for EGDS; conversely, 874 EGDS were prescribed through OAS (M:F = 383:491; median age 58 yrs, IQR 45.68). Indication was appropriate in 92% in GAS (1312/1424) versus 71% in OAS (618/874), < 0.001. The rate of clinically significant endoscopic findings (CSEF) was significantly higher in GAS (49% vs. 34.8%, < 0.001). Adherence to ASGE guidelines was not related to CSEF; however, surveillance for pre-malignant conditions was independently related to CSEF. All neoplasm were observed in appropriate EGD. GAS is an innovative method showing extremely high rates of appropriateness. ASGE guidelines confirmed their validity for cancer detection, but their performance for the detection of other conditions needs to be refined.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12093343